Orphan Drug Patents: Concerns Raised by Payers and Policy Makers

This article was originally published at https://www.drugpatentwatch.com/blog/orphan-drug-patents-concerns-raised-by-payers-and-policy-makers/

There are more than 7,000 diseases that are considered “rare,” that is, affecting fewer than 200,000 Americans. Yet around one in ten Americans lives with at least one of these… The post Orphan Drug Patents: Concerns Raised by Payers and Policy Makers appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Biotechblog